Danish renewable power developer Ørsted has successfully raised DKK60 billion (US$9.4 billion) through a rights issue, where current stockholders are given the right to purchase additional shares in the company. Ørsted announced on 6 October…
Category: 6. Business
-

Euro area quarterly balance of payments and international investment position: second quarter of 2025
7 October 2025
- Current account surplus at €326 billion (2.1% of euro area GDP) in four quarters to second quarter of 2025, after a €396 billion surplus (2.7% of GDP) a year earlier
- Geographical counterparts: largest bilateral current account…
Continue Reading
-
Resolution Therapeutics to present EMERALD study design at the British Association for the Study of the Liver (BASL) annual meeting 2025
– EMERALD Chief Investigator Prof. Jonathan Fallowfield will present the poster on study design
– EMERALD is a multicentre Phase I/II study evaluating Resolution’s…Continue Reading
-

TDK wins Innovation Award in CEATEC 2025
TDK Corporation (TSE:6762) announces that TDK’s prototype of an analog reservoir AI chip won the Innovation Award at CEATEC 2025.
The CEATEC AWARD 2025 is presented to outstanding exhibited products, technologies, and services…
Continue Reading
-
Generative AI and news report 2025: How people think about AI’s role in journalism and society
Introduction
The last year has seen a rapid growth in the public use of generative AI tools and systems and continued development of the features and performance on offer. Many businesses say they have not yet seen any clear benefits from their…
Continue Reading
-

German industrial order books remain empty as US front-loading ends | snaps
Since March this year (the month after the German elections and before Donald Trump’s ‘Liberation Day’), industrial orders have on average increased by 0.1% every month. This headline number, however, masks significant differences between…
Continue Reading
-

Tumor-Specific MHC-II Predicts Immunotherapy Response in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options and high relapse rates. The incorporation of immune checkpoint inhibitors (ICIs), particularly anti–PD-1/PD-L1 agents, into…
Continue Reading
-

Identification of Key Biomarkers and Immune Microenvironment Features
Introduction
Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) characterized by recurrent episodes of relapse and remission. As of 2023, it is estimated that approximately 5 million individuals are affected by UC globally,…
Continue Reading
-

Exclusive-Novo Nordisk cuts hit production line jobs at key US plant, posts show
By Maggie Fick and Soren Jeppesen
LONDON/COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk has laid off dozens of employees at the largest U.S. manufacturing site for its blockbuster obesity and diabetes drugs, a Reuters review of LinkedIn posts…
Continue Reading
-
Exclusive: Novo Nordisk cuts hit production line jobs at key US plant, posts show – Reuters
- Exclusive: Novo Nordisk cuts hit production line jobs at key US plant, posts show Reuters
- MNC job cuts comes calling on India employees Deccan Herald
- Ozempic maker Novo Nordisk to lay off up to 150 people in India as part of global cuts Mint
- SAP,…
Continue Reading
